This study identified that MYC-dependent breast cancer cells possess high MYC expression and high level of MYC phosphorylation, and are sensitive to inhibition of CDK1, but not CDK4/6 and CDK2, suggesting that high MYC expression in breast cancer cells is associated with selective synthetic lethality induced by CDK1 inhibition. Here, CDK2 is linked to breast cancer.